Pieris Pharmaceuticals, Inc. - Common Stock (PIRS)
13.60
0.00 (0.00%)
Pieris Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on discovering and developing innovative protein-based therapeutics
The company's proprietary Anticalin technology platform is designed to create targeted treatments for a variety of diseases, including cancer and respiratory disorders. By engineering proteins that can bind specifically to disease-related targets, Pieris aims to enhance the efficacy and safety of its therapeutic candidates. The company is actively involved in advancing its pipeline of drug candidates through clinical trials, seeking to address unmet medical needs in the pharmaceutical landscape.
Frequently Asked Questions
Is Pieris Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Pieris Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Pieris Pharmaceuticals, Inc. - Common Stock trade on?
Pieris Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pieris Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Pieris Pharmaceuticals, Inc. - Common Stock is PIRS on the Nasdaq Stock Market
What is the current price of Pieris Pharmaceuticals, Inc. - Common Stock?
The current price of Pieris Pharmaceuticals, Inc. - Common Stock is 13.60
When was Pieris Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Pieris Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on December 13th, 2024
What is the market capitalization of Pieris Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Pieris Pharmaceuticals, Inc. - Common Stock is 1.35B
How many shares of Pieris Pharmaceuticals, Inc. - Common Stock are outstanding?
Pieris Pharmaceuticals, Inc. - Common Stock has 98.94M shares outstanding.